New Haven Connecticut based AtlasXomics is raising $3,500,003.00 in New Equity Investment.
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, AtlasXomics is raising $3,500,003.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kenneth Wang played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About AtlasXomics
Developer of imaging technology designed to give researchers insight into the genomics, transcriptomics, and proteomics landscapes driving forward biological discovery. AtlasXomics’ revolutionary spatial imaging technique gives researchers unprecedented insight into the genomics, transcriptomics, and proteomics landscapes driving forward biological discovery. AtlasXomics is a New Haven, Connecticut-based biotechnology company that operates in stealth.
To learn more about AtlasXomics, visit http://www.atlasxomics.com/
Contact:
Kenneth Wang, Chief Executive Officer
917-841-1327
SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved